BeOne Medicines Statistics Share Statistics BeOne Medicines has 106.86M
shares outstanding. The number of shares has increased by -9.18%
in one year.
Shares Outstanding 106.86M Shares Change (YoY) -9.18% Shares Change (QoQ) -11.68% Owned by Institutions (%) n/a Shares Floating 67.13M Failed to Deliver (FTD) Shares 959 FTD / Avg. Volume 0.26%
Short Selling Information The latest short interest is 1.57M, so 1.43% of the outstanding
shares have been sold short.
Short Interest 1.57M Short % of Shares Out 1.43% Short % of Float 2.03% Short Ratio (days to cover) 3.28
Valuation Ratios The PE ratio is -30.16 and the forward
PE ratio is 48.63.
BeOne Medicines's PEG ratio is
1.09.
PE Ratio -30.16 Forward PE 48.63 PS Ratio 5.1 Forward PS 5.6 PB Ratio 5.84 P/FCF Ratio -29.04 PEG Ratio 1.09
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for BeOne Medicines.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.8,
with a Debt / Equity ratio of 0.32.
Current Ratio 1.8 Quick Ratio 1.58 Debt / Equity 0.32 Debt / EBITDA -2.72 Debt / FCF -1.61 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $346.39K Profits Per Employee $-58.62K Employee Count 11,000 Asset Turnover 0.64 Inventory Turnover 1.2
Taxes Income Tax 111.78M Effective Tax Rate -20.97%
Stock Price Statistics The stock price has increased by 49.28% in the
last 52 weeks. The beta is 0.21, so BeOne Medicines's
price volatility has been higher than the market average.
Beta 0.21 52-Week Price Change 49.28% 50-Day Moving Average 313.79 200-Day Moving Average 254.54 Relative Strength Index (RSI) 50.91 Average Volume (20 Days) 369,538
Income Statement In the last 12 months, BeOne Medicines had revenue of 3.81B
and earned -644.79M
in profits. Earnings per share was -6.12.
Revenue 3.81B Gross Profit 3.22B Operating Income -568.2M Net Income -644.79M EBITDA -396.44M EBIT -568.2M Earnings Per Share (EPS) -6.12
Full Income Statement Balance Sheet The company has 2.63B in cash and 1.08B in
debt, giving a net cash position of 1.55B.
Cash & Cash Equivalents 2.63B Total Debt 1.08B Net Cash 1.55B Retained Earnings -8.61B Total Assets 6.3B Working Capital 2.1B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -140.63M
and capital expenditures -529.14M, giving a free cash flow of -669.77M.
Operating Cash Flow -140.63M Capital Expenditures -529.14M Free Cash Flow -669.77M FCF Per Share -6.36
Full Cash Flow Statement Margins Gross margin is 84.41%, with operating and profit margins of -14.91% and -16.92%.
Gross Margin 84.41% Operating Margin -14.91% Pretax Margin -13.99% Profit Margin -16.92% EBITDA Margin -10.4% EBIT Margin -14.91% FCF Margin -17.58%
